HCSGD entry for SCN10A
1. General information
| Official gene symbol | SCN10A |
|---|---|
| Entrez ID | 6336 |
| Gene full name | sodium channel, voltage-gated, type X, alpha subunit |
| Other gene symbols | Nav1.8 PN3 SNS hPN3 |
| Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
|---|---|---|---|
| GO:0001518 | Voltage-gated sodium channel complex | IDA | cellular_component |
| GO:0002027 | Regulation of heart rate | IMP | biological_process |
| GO:0005248 | Voltage-gated sodium channel activity | IDA | molecular_function |
| GO:0006814 | Sodium ion transport | TAS | biological_process |
| GO:0007600 | Sensory perception | TAS | biological_process |
| GO:0034765 | Regulation of ion transmembrane transport | IDA | biological_process |
| GO:0035725 | Sodium ion transmembrane transport | IDA | biological_process |
| GO:0044299 | C-fiber | IEA | cellular_component |
| GO:0055117 | Regulation of cardiac muscle contraction | IMP | biological_process |
| GO:0060371 | Regulation of atrial cardiac muscle cell membrane depolarization | IMP | biological_process |
| GO:0086067 | AV node cell to bundle of His cell communication | IMP | biological_process |
| GO:0086069 | Bundle of His cell to Purkinje myocyte communication | IMP | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
| p-value up | p-value down | FDR up | FDR down |
|---|---|---|---|
| 0.6783793701 | 0.7830424338 | 0.9999902473 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
| Data source | Up or down | Log fold change |
|---|---|---|
| GSE11954 | Down | -0.2139485182 |
| GSE13712_SHEAR | Down | -0.0553155308 |
| GSE13712_STATIC | Down | -0.0376082140 |
| GSE19018 | Up | 0.1357321406 |
| GSE19899_A1 | Up | 0.1025294471 |
| GSE19899_A2 | Up | 0.3163727591 |
| PubMed_21979375_A1 | Down | -0.1131172036 |
| PubMed_21979375_A2 | Up | 0.1542049380 |
| GSE35957 | Up | 0.2406546657 |
| GSE36640 | Down | -0.0054255797 |
| GSE54402 | Down | -0.0101608287 |
| GSE9593 | Up | 0.0170202010 |
| GSE43922 | Up | 0.0146087008 |
| GSE24585 | Up | 0.0968762935 |
| GSE37065 | Down | -0.1098936747 |
| GSE28863_A1 | Down | -0.0282922328 |
| GSE28863_A2 | Up | 0.0659538415 |
| GSE28863_A3 | Up | 0.0748907175 |
| GSE28863_A4 | Down | -0.0055998291 |
| GSE48662 | Up | 0.0477121230 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
|---|---|---|
| Lidocaine | DB00281 | APRD00479 | DB05291 |
| Ropivacaine | DB00296 | APRD00492 |
| Bupivacaine | DB00297 | APRD00247 |
| Hexylcaine | DB00473 | APRD01014 |
| Proparacaine | DB00807 | APRD00522 |
| Mepivacaine | DB00961 | APRD01094 |
| Levobupivacaine | DB01002 | APRD00110 |
| Benzocaine | DB01086 | APRD00539 |
| Chloroprocaine | DB01161 | APRD00404 |
| Lacosamide | DB06218 | - |

